Protagenic Therapeutics Stock (NASDAQ: PTIX) stock price, news, charts, stock research, profile.
Open | $0.70 |
Close | $0.70 |
Volume / Avg. | 2.00K / 13.13K |
Day Range | 0.70 - 0.72 |
52 Wk Range | 0.68 - 2.22 |
Market Cap | $3.12M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 0.3% |
Days to Cover | 1.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protagenic Therapeutics (NASDAQ:PTIX) through any online brokerage.
Other companies in Protagenic Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO) and Quoin Pharmaceuticals (NASDAQ:QNRX).
There is no analysis for Protagenic Therapeutics.
Protagenic Therapeutics has a consensus price target of $4.00.
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $0.7001 last updated July 29, 2024 at 3:28 PM EDT.
There are no upcoming dividends for Protagenic Therapeutics.
Protagenic Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Protagenic Therapeutics.
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.